← Eichor
Study identifier: NCT06481540 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

SpiroGym App-Aided Cough Rehabilitation

Condition: Parkinson Disease · Voluntary Peak Cough Strength · mHealth  ·  Sponsor: General University Hospital, Prague

PhaseNA
Planned participants60
Who can joinAll sexes, 40 Years to 80 Years
Healthy volunteersNo

About this study

The pilot study by Srp et al. (2021) proved that the SpiroGym app was feasible for supporting expiratory muscle strength training (EMST) in Parkinson's disease (PD) patients. Two weeks of intensive EMST coupled with SpiroGym were sufficient to significantly improve the participants' voluntary peak cough flow (PCF). The improvement was quantitatively comparable to the results of other intensive EMST studies with longer durations. When interpreting such rapid improvement, the impact of SpiroGym's visual feedback was considered. It was assumed that visual feedback increased training effort compared to regular training without immediate control. However, comparative studies were required to verify the possible additional effects of visual feedback on voluntary PCF compared to EMST without feedback.

This description comes directly from the study's public registry record.

Talk to the study team

Martin Srp, PhD  ·  +420224965513  ·  martin.srp@vfn.cz

Always discuss trial participation with your own doctor first.

Locations (1)

General University HospitalPrague, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06481540